Neuroblastoma is the most common cancer found in infants.

Neuroblastoma is a rare cancer of the sympathetic nervous system; a nerve network that carries messages from the brain throughout the body. These solid tumors which take the form of a lump or mass may begin in nerve tissues in the neck, chest, abdomen, pelvis, or most commonly in the adrenal gland. They may also spread to other areas of the body, including bone and bone marrow.

The median age for tumor discovery is two years, and it occurs somewhat more in boys than girls. Its frequency is second only to brain tumors and it is seldom seen in children over 14 years old.

The Cook Children's Neuroblastoma Program leads the way in cutting edge research.

As in previous years, our 2014 proceeds will go directly to Cook Children’s.  In 2008, Cook Children’s was selected to join the New Approaches to Neuroblastoma Therapy (NANT) consortium, an organization comprised of just 15 hospitals throughout the United States specializing in neuroblastoma research.  Through the collaboration with NANT, Cook Children’s is currently enrolling patients in new clinical trials offering the leading edge of care for neuroblastoma.